{"id":733,"date":"2021-05-10T06:35:18","date_gmt":"2021-05-10T01:05:18","guid":{"rendered":"http:\/\/www.cscr.in\/symposium21\/?page_id=733"},"modified":"2022-09-05T12:42:54","modified_gmt":"2022-09-05T07:12:54","slug":"cgts-sep-2021","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/cgts-sep-2021\/","title":{"rendered":"CGTS 2021"},"content":{"rendered":"

\"\"<\/h1>\n

PROGRAMME SCHEDULE<\/strong><\/span><\/h1>\n

CGTS 2021 SCIENTIFIC PROGRAM \u2013 Click to view \/ Download<\/strong><\/span><\/a><\/h3>\n

Time shown in IST (Indian Standard Time)<\/em><\/span><\/p>\n

DAY-1: Wednesday, 1st  <\/sup>SEPTEMBER, 2021<\/strong><\/span><\/h2>\n\n\n\n
\n

1:00 to 1:05 PM               Prayer by Chaplain<\/p>\n

1:05 to 1:15 PM                Welcome and introductory remarks: Director, CMC \/ Principal,                                                                                    CMC \/ Director, inStem\/ Head, CSCR<\/p>\n

1:15 to 1:25 PM                Remarks by Secretary, Department of Biotechnology, Ministry of                                                                              Science and Technology, Govt. of India<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n
\n

 KEY NOTE ADDRESS<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
1:30 to 2:30 PM<\/td>\n\n

Gene therapy and gene editing for genetic diseases and cancer: a personal journey<\/p>\n<\/td>\n

\n

Thierry Vanden Driessche<\/strong>
Free University of Brussels &
University of Leuven, Belgium<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
 <\/td>\nSession-1:  APPLICATIONS OF iPSC TECHNOLOGY<\/strong><\/span><\/td>\n<\/tr>\n
 Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
\n

2.30 to 3:00 PM<\/p>\n<\/td>\n

\n

iPSC based disease modelling of bone marrow failure diseases<\/p>\n

<\/p>\n<\/td>\n

\n

RV Shaji<\/strong>
Centre for Stem Cell Research, India<\/p>\n<\/td>\n<\/tr>\n

3:00 to 3:30 PM<\/td>\nThe EBiSC iPSC bank for disease research<\/td>\n\n

Rachel Steeg<\/strong>
Fraunhofer UK Research Limited, Scotland, UK<\/p>\n<\/td>\n<\/tr>\n

3:30 to 4:00 PM<\/td>\niPSC-based disease-modelling of Fanconi anaemia<\/td>\nGrant Rowe<\/strong>
Boston Children\u2019s Hospital and Dana-Farber Cancer Institute, Cambridge, USA<\/td>\n<\/tr>\n
4:00 to 4:15 PM<\/td>\n                                                             Break<\/strong><\/td>\n<\/tr>\n
4:15 to 5:00 PM<\/td>\n\n

                                           <\/strong>Poster presentation\/ Industry Symposium<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

 <\/td>\nSession-2: TECHNOLOGY ADVANCES<\/strong><\/span><\/td>\n<\/tr>\n
  Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
5:00 to 5:30 PM<\/td>\nGenome editing for Sickle cell disease<\/td>\n\n

Martin H. Steinberg<\/strong>
Boston University and Boston Medical Centre, Boston<\/p>\n<\/td>\n<\/tr>\n

\n

5:30 to 6:00 PM<\/p>\n

<\/p>\n<\/td>\n

\n

Turning Genes into Medicines: Lessons Learned in the Pursuit of Gene Therapy for Haemophilia<\/p>\n<\/td>\n

\n

Katherine A. High<\/strong>
Asklepios BioPharmaceutical, Inc (AskBio), North Carolina, USA<\/p>\n<\/td>\n<\/tr>\n

\n

6:00 to 6:30 PM<\/p>\n<\/td>\n

\n

Preferential expansion of hematopoietic stem cells enhances gene-modified cell frequency for gene therapy<\/p>\n<\/td>\n

\n

Saravanabhavan Thangavel       <\/strong>Centre for Stem Cell Research, Vellore, India<\/p>\n<\/td>\n<\/tr>\n

6:30 to 6:45PM<\/td>\n                                                               Break<\/strong><\/td>\n<\/tr>\n
 <\/td>\n <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n
\n

                            Session-3: GENE THERAPY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

6:45 to 7:15 PM<\/td>\n\n

Development of capsid- and genome-modified AAVrh74 vectors for gene therapy of muscular dystrophies<\/p>\n<\/td>\n

\n

Arun Srivastava                                <\/strong>University of Florida College of Medicine, USA<\/p>\n<\/td>\n<\/tr>\n

7:15 to 7:45 PM<\/td>\n\n

Validation of BCL11A as a Therapeutic Target in Sickle Cell Disease: Results from a First-in-Human Clinical Trial<\/p>\n<\/td>\n

\n

David Williams                                    <\/strong>Harvard Stem Cell Institute
Bauer Building, Cambridge, USA<\/p>\n<\/td>\n<\/tr>\n

7:45 to 8:15 PM<\/td>\nLentiviral vector-based gene therapy for Haemophilia A<\/td>\n\n

Alok Srivastava                                  <\/strong>Centre for Stem Cell Research, Vellore, India<\/p>\n<\/td>\n<\/tr>\n

 <\/td>\n\n

End of Day-<\/strong>1<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n

DAY-2: Thursday, 2nd<\/sup><\/strong><\/span>  <\/sup>SEPTEMBER, 2021<\/strong><\/span><\/h2>\n\n\n\n\n\n\n\n
Session-4: MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n
3:00 to 3:30 PM<\/td>\nManufacturing and clinical application of mesenchymal stromal cells for diabetic complications<\/td>\n\n

Timothy O\u2019brien                                <\/strong>National University of Ireland, Galway, Ireland<\/p>\n<\/td>\n<\/tr>\n

3:30 to 4:00 PM<\/td>\n\n

Manufacturing the vector and CAR-T cells in India \u2013 The nuts and bolts<\/p>\n<\/td>\n

\n

Rahul Purwar                                    <\/strong>Indian Institute of Technology Bombay, Mumbai, India<\/p>\n<\/td>\n<\/tr>\n

4:00 to 4:30 PM<\/td>\n\n

Engineering Genetically Enhanced T cells for clinical applications<\/p>\n<\/td>\n

\n

Bruce Levine                                      <\/strong>Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA<\/p>\n<\/td>\n<\/tr>\n

4:30 to 4:45 PM<\/td>\n\n

Break<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n
\n

Session-5: CELL AND GENE THERAPY FOR OCULAR DISORDERS<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

4:45 to 5:15 PM<\/td>\nRegenerative medicine by epithelia: increasing the complexity<\/td>\n\n

Graziella Pellegrini                      <\/strong>University of Modena and Reggio Emilia, Modena, Italy<\/p>\n<\/td>\n<\/tr>\n

5:15 to 5:45 PM<\/td>\nGene augmentation strategies for corneal conditions<\/td>\n\n

Arkasubhra Ghosh                        <\/strong>Narayana Netralaya, Bengaluru, India<\/p>\n<\/td>\n<\/tr>\n

5:45 to 6:15 PM<\/td>\n\n

Advances in iPSC-derived outer retina tissue mimetic: Implications for translational approaches towards cell and gene-based therapy<\/p>\n<\/td>\n

\n

Ruchira Singh                                      <\/strong>University of Rochester, NewYork, USA<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
6:15 to 7:00 PM<\/td>\n                  Poster presentation\/ Industry Symposium<\/span><\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n
\n

Session-6: <\/em><\/strong>IMMUNE CELL THERAPY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

7:00 to 7:30 PM<\/td>\nNK cell therapy in the treatment of liquid and solid tumors<\/td>\n\n

Rizwan Romee<\/strong>
Harvard Medical School, Dana Farber Cancer Institute, Boston, USA<\/p>\n<\/td>\n<\/tr>\n

7:30 to 8:00 PM<\/td>\n\n

Developing genetically-engineered, clinically-scalable, \u03b3\u03b4 T Cells for the treatment of solid tumours and hematopoietic cancers of children<\/p>\n

 <\/strong><\/p>\n<\/td>\n

\n

Trent Spencer                                   <\/strong>Emory University, School of Medicine, USA<\/p>\n<\/td>\n<\/tr>\n

8:00 to 8:30 PM<\/td>\nThe first indigenous CAR-T cells in India \u2013 From bench to clinic<\/td>\n\n

Rahul Purwar                                    <\/strong>Indian Institute of Technology Bombay, Mumbai, India<\/p>\n<\/td>\n<\/tr>\n

8:30 to 9:00 PM<\/td>\nVeto cells in haplo-transplantation and immune cell therapy<\/td>\n\n

Yair Reisner                                      <\/strong>MD Anderson Cancer Centre, Houston, TX, USA<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

End of Day-2<\/strong><\/p>\n

DAY-3: Friday, 3rd<\/sup><\/strong><\/span>  <\/sup>SEPTEMBER, 2021<\/strong><\/span><\/h2>\n\n\n\n\n\n\n\n
\n

Session-7: CELL AND GENE THERAPY- INDUSTRY UPDATES<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

3:00 to 3:30 PM<\/td>\nQuality by Design: Reagents and Support for hPSC-Derived Cell and Gene Therapies<\/td>\nKimberly Snyder                            <\/strong>Stem Cell Technologies,            Vancouver, Canada<\/td>\n<\/tr>\n
3:30 to 4:00 PM<\/td>\nDevelopment of a scalable adeno-associated virus production process by transient transfection in suspension cells<\/td>\nAnn-Christin Magnusson            <\/strong>Cytiva, Uppsala, Sweden<\/td>\n<\/tr>\n
4:00 to 4:30 PM<\/td>\nAllogenic Cell and Gene therapy workflows with NK Cells<\/td>\nMohan C. Vemuri                          <\/strong>Thermo Fisher Scientific Maryland, USA<\/td>\n<\/tr>\n
4:30 to 4:45 PM<\/td>\n\n

Break<\/em><\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session-8: GENE EDITING<\/strong><\/span><\/td>\n<\/tr>\n
India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
4:45 to 5:15 PM<\/td>\n\n

Identification of novel HPFH-like mutations by CRISPR base editing that elevates the expression of fetal hemoglobin<\/p>\n<\/td>\n

\n

Mohankumar Murugesan            <\/strong>Centre for Stem Cell Research, Vellore, India<\/p>\n<\/td>\n<\/tr>\n

5:15 to 5:45 PM<\/td>\n\n

Genome editing of hematopoietic stem cells<\/p>\n<\/td>\n

\n

Pietro Genovese                                <\/strong>Harvard Medical School, Boston, USA<\/p>\n<\/td>\n<\/tr>\n

5:45 to 6:15 PM<\/td>\nBase editing of hematopoietic stem cells rescues sickle cell disease in mice<\/td>\n\n

Jonathan Yen                                      <\/strong>St. Jude Children\u2019s Research Hospital, Memphis, USA<\/p>\n<\/td>\n<\/tr>\n

6:15 to 7:00 PM<\/td>\n\n

                  Poster presentation\/ Industry Symposium<\/span><\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Session-9: NON-VIRAL NUCLEIC ACID TRANSFER<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
7:00 to 7:30 PM<\/td>\nNanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease<\/td>\n\n

Avinash Bajaj                                    <\/strong>Regional Center for Biotechnology, New Delhi<\/p>\n<\/td>\n<\/tr>\n

\n

7:30 to 8:00 PM<\/p>\n<\/td>\n

\n

Development of Liver targeting lipid enabled nucleic acid delivery systems for therapeutic applications<\/p>\n<\/td>\n

\n

Srujan Marepally                            <\/b>Centre for Stem Cell Research, India<\/p>\n

<\/p>\n<\/td>\n<\/tr>\n

\n

8:00 to 8:30 PM<\/p>\n<\/td>\n

\n

Self-transcribing and replicating RNA based vaccine for  SARS-CoV-2<\/p>\n<\/td>\n

\n

Priya Prakash Karmali                 <\/strong>Arcturus Therapeutics, San Diego, USA<\/p>\n<\/td>\n<\/tr>\n

\n

End of Day-3<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/h3>\n\n\n
\"\"<\/figure>\n\n\n\n

CGTS 2021 E-POSTER Part-1 \u2013 Click to view \/ download<\/a><\/p>\n

CGTS 2021<\/a> <\/a>E-POSTER Part-2 \u2013 Click to view \/ download<\/a><\/p>\n

CGTS 2021 ABSTRACT BOOK \u2013 Click to view \/ download<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

PROGRAMME SCHEDULE CGTS 2021 SCIENTIFIC PROGRAM \u2013 Click to view \/ Download Time shown in IST (Indian Standard Time) DAY-1: Wednesday, 1st  SEPTEMBER, 2021 1:00 to 1:05 PM               Prayer by Chaplain 1:05 to 1:15 PM                Welcome and introductory remarks: Director, CMC \/ Principal,    […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/733"}],"collection":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/comments?post=733"}],"version-history":[{"count":77,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/733\/revisions"}],"predecessor-version":[{"id":1554,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/733\/revisions\/1554"}],"wp:attachment":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/media?parent=733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}